(53 days)
Not Found
No
The document describes a personal lubricant and its biocompatibility and condom compatibility testing. There is no mention of AI, ML, image processing, or any other technology that would suggest the use of AI/ML.
No
The device is described as a personal lubricant intended to enhance the ease and comfort of intimate sexual activity, primarily for lubrication and moisturization. It does not claim to treat, prevent, or diagnose any disease or condition.
No
This device is described as a personal lubricant intended to enhance the ease and comfort of intimate sexual activity, and studies focus on its biocompatibility and condom compatibility, not on diagnosing any medical condition.
No
The device description and performance studies clearly indicate this is a physical liquid lubricant, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is clearly stated as a personal lubricant for intimate sexual activity, applied to vaginal or penile tissue. This is a topical application for physical lubrication and comfort, not for diagnosing a condition or analyzing a sample from the body.
- Device Description: The description reinforces its function as a personal lubricant.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information about a patient's health status.
- Performance Studies: The performance studies focus on biocompatibility (skin irritation, sensitization) and condom compatibility, which are relevant to a personal lubricant, not an IVD.
IVD devices are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening. This device does not fit that description.
N/A
Intended Use / Indications for Use
Warming Liquid Personal Lubricant is primarily intended as a personal lubricant to warming bigule I crocion, and to enhance the ease and comfort of intimate sexual activity. This lubricant may be safely applied to vaginal or penile tissue for purposes of lubrication, and moisturization. It is also compatible with latex condoms.
Product codes
NUC
Device Description
PharmaPac Warming Liquid is a non-sterile, clear, non-staining, non-greasy, liquid I harmal as a personal lubricant. This product is highly lubricous and may be used with or without a latex condom during intimate sexual activity. Warming Liquid with or without a later of a contraceptive or spermicide. It is compatible with latex condoms.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vaginal, or penile tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Performance Data:
Informatics were conducted on Warming Liquid Personal Lubricant by an outside In VIVO Standor Woonstrated the Biocompatibility of Warming Liquid Personal Lubricant by the following results.
Dermal Sensitization Study (Guinea Pig) – The product exhibited no evidence being a contact sensitizing agent in albino guinea pigs.
a Contact schildling agent in distress growth of this product to the rabbit I enine ITT liation Order on microscopic tissue examination showed no significant irritation.
Significant Irritation:
Vaginal Irritation Study (Rabbit) – Repeated Direct administration of Warming Vaginal in Huation Diday (Fuse rabbit vagina and subsequent macroscopic and microscopic tissue examination showed no significant irritation of the vaginal mucosa.
Systemic Injection Study (Mouse) – The product was administered to the animals at Systemic Infection Study (Mouse) - 1.1. p mortality and was not associated with systemic toxicity.
Studies Condom compatibility were also conducted on Warming Liquid Personal Studies Concom companonity were association was tested in parallel with the predicate Lubricant by a thru-party hooffacts ... ... ... ... ... ... ... ... ... ... .. .. .. .. .. .. .. .. several brands and varieties of latex condoms were tested.
Several brancs and varieties of faces contemb with the test lubricants exhibited Deak testing - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Burst testing - Application of the test lubricants showed no significant difference in Durst testing - results for burst pressure or burst volume.
the treathent groups Tesans for barb process force, ultimate tensile strength, and I elisite testing - No decrease in the oreal voted when comparing the two lubricants.
In an Accelerated Stability Study the Warming Liquid Personal Lubricant was stored In an Accelerated Bulling Stary ate Alantintervals. The testing showed that at every at 40 ℃ and tested ut 0, 50, 00, and 70 day and remained within specifications testing ovent the production a 24 month shelf life may be supported by this data.
The testing and evaluation of this formulation has demonstrated scientific evidence that this product is safe for its intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.5300 Condom.
(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.
0
K052974
510(k) Summary
| Submitter | PharmaPac, LLC
110 Industrial Park Road
DeKalb, MS 39328 |
|---------------------|----------------------------------------------------------------|
| Contact Person | Tom Otto
(601) 743-9771 phone
(601) 743-9772 fax |
| Date Prepared | September 12, 2005 |
| Proprietary Name | PharmaPac Warming Liquid Personal Lubricant |
| Common Name | Personal Lubricant |
| Classification Name | Patient Lubricant (per 21 CFR § 880.6375) |
| Predicate Device | K-Y® Warming Liquid Personal Lubricant (K021492) |
Description of Device
PharmaPac Warming Liquid is a non-sterile, clear, non-staining, non-greasy, liquid I harmal as a personal lubricant. This product is highly lubricous and may be used with or without a latex condom during intimate sexual activity. Warming Liquid with or without a later of a contraceptive or spermicide. It is compatible with latex condoms.
Intended Use
Warming Liquid Personal Lubricant is primarily intended as a personal lubricant to wanning Digure friction, and to enhance the ease and comfort of intimate sexual monstanze, roneve methon, and refely applied to vaginal, or penile tissue for purposes activity. This fubrican maj ation. It is also compatible with latex condoms.
Technological Characteristics of Device Compared to Predicate
The technology involved in this product has no remarkable technological The techniology involvou in in the province soluble ingredients similar to other lubricants which are currently on the market. A comparison of technological Idoricallis wither are outromiy on the substantial equivalence of Warming Liquid Characteristics which domonstration and summarized in the Table below:
1
510(k) Summary (Cont.)
Comparison of Characteristics
| Characteristic / Feature | PharmaPac
Warming Liquid
Personal Lubricant | K-Y® Brand
Warming Liquid
(K021492) |
|---------------------------------------|---------------------------------------------------|-------------------------------------------|
| Contains Glycerin | Yes | Yes |
| Contains Thickening Agents | Yes | Yes |
| Contains Preservative Agents | Yes | Yes |
| Contains Petroleum based
Chemicals | No | No |
| Container Material | Plastic | Plastic |
| Sterile | No | No |
Performance Data
I er formatics were conducted on Warming Liquid Personal Lubricant by an outside In VIVO Standor Woonstrated the Biocompatibility of Warming Liquid Personal Lubricant by the following results.
Dermal Sensitization Study (Guinea Pig) – The product exhibited no evidence being a contact sensitizing agent in albino guinea pigs.
a Contact schildling agent in distres growth of this product to the rabbit I enine ITT liation Order on microscopic tissue examination showed no significant irritation.
Stgifficant Irritation:
Vaginal Irritation Study (Rabbit) – Repeated Direct administration of Warming V aginal in Huation Diday (Fuse rabbit vagina and subsequent macroscopic and microscopic tissue examination showed no significant irritation of the vaginal mucosa.
Indecsa.
Systemic Injection Study (Mouse) – The product was administered to the animals at Systemic Infection Study (Mouse) - 1.1. p mortality and was not associated with systemic toxicity.
Studies Condom compatibility were also conducted on Warming Liquid Personal Studies Concom companonity were association was tested in parallel with the predicate Lubricant by a thru-party hooffacts ... ... ... ... ... ... ... ... ... ... .. .. .. .. .. .. .. .. several brands and varieties of latex condoms were tested.
Several brancs and varieties of faces contemb with the test lubricants exhibited Deak testing - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Burst testing - Application of the test lubricants showed no significant difference in Durst testing - results for burst pressure or burst volume.
the treathent groups Tesans for barb process force, ultimate tensile strength, and I elisite testing - No decrease in the oreal voted when comparing the two lubricants.
2
KO52974
510(k) Summary (Cont.)
In an Accelerated Stability Study the Warming Liquid Personal Lubricant was stored In an Accelerated Bulling Stary ate Alantintervals. The testing showed that at every at 40 ℃ and tested ut 0, 50, 00, and 70 day and remained within specifications testing ovent the production a 24 month shelf life may be supported by this data.
The testing and evaluation of this formulation has demonstrated scientific evidence that this product is safe for its intended use.
3
Image /page/3/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three curved lines representing its body and wings. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" surrounding it. The text is written in all capital letters.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
FEB 2 4 2014
PharmaPac, LLC % Mr. Mark Job Responsible Third Party Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
Re: K052974
Trade/Device Name: PharmaPac Warming Liquid Personal Lubricant Regulation Number: 21 CFR §884.5300 Regulation Name: Condom Regulatory Class: II Product Code: NUC Dated (Date on orig SE ltr): November 12, 2005 Received (Date on orig SE ltr): November 14, 2005
Dear Mr. Job:
This letter corrects our substantially equivalent letter of December 16, 2005.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be
4
Page 2 -
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
| 510(k) Number (if known): | (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1 | ||
|---|---|---|---|
| --------------------------- | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -- |
Device Name: . PharmaPac Warming Liquid Personal Lubricant
Indications for Use:
Warming Liquid Personal Lubricant is primarily intended as a personal lubricant to warming bigule I crocion, and to enhance the ease and comfort of intimate sexual activity. This lubricant may be safely applied to vaginal or penile tissue for purposes of lubrication, and moisturization. It is also compatible with latex condoms.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use X (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
радительных провых провых ставляется продавания продавания продавания принастические принасления с
NancyL Brogdon
inminal.
Ko52974